Laboratory
This content takes an average of 5 minutes

Tests starting with the letter M

Laboratory Test Guide: Tests Starting with the Letter "M"

A complete list of all tests beginning with the letter "M" performed at Egemed Hospitals’ Medical Laboratories is provided below. To help our patients understand these tests, a brief medical description and the purpose of each test in the laboratory are clearly stated.

Biochemistry, Hormone, and Metabolism Tests

Magnesium 24-Hour Urine

Description: This test measures the amount of magnesium—a key component of the body’s muscle and nervous systems—excreted by the kidneys over a 24-hour period.

Purpose: This test is used to assess whether the kidneys are retaining magnesium and to determine the cause of unexplained low magnesium levels.

MAGNESIUM Intracellular

Description: This is a much more sensitive test that measures the level of magnesium stored within the cells (red blood cells) by directly entering them.

Purpose: To detect "hidden" and chronic magnesium deficiency that exists at the cellular level despite appearing normal in routine blood tests.

Macroprolactin

Description: This is the separation of the biologically inactive "large-molecule" structure formed by the milk hormone prolactin as it binds to antibodies in the blood.

Objective: To prevent unnecessary medication or MRI treatments in patients with elevated prolactin levels by determining whether the elevation is due to a false-positive result.

Metanephrine, 24-Hour, Urine

Description: This test measures the level of metanephrine—a molecule formed by the breakdown of the stress hormone adrenaline—in a 24-hour urine collection.

Purpose: It is one of the gold standard methods for diagnosing severe episodes of high blood pressure and pheochromocytoma (a tumor of the adrenal gland).

Metanephrines in 24-hour urine

Description: This test involves the simultaneous screening of the breakdown products of all catecholamines (adrenaline/norepinephrine) secreted by the adrenal glands in a 24-hour urine sample.

Purpose: This test is ordered for the general diagnosis of neuroendocrine tumors presenting with palpitations, sweating, and persistent hypertension.

METHANEPHRINES Free Plasma

Description: This involves measuring metanephrine molecules in their free form directly in the bloodstream (plasma) before they are excreted in the urine.

Purpose: This test provides the earliest warning sign for the diagnosis of pheochromocytoma and has the highest sensitivity.

META-EPINEPHRINES Spot Urine

Description: This procedure involves screening for the total metanephrine panel using a spot urine sample collected at any time of day.

Purpose: To perform a rapid initial screening for adrenal gland abnormalities in patients for whom 24-hour urine collection is difficult (particularly in children).

METANEPHRINE Spot Urine

Description: This is the specific analysis of the "metanephrine" molecule alone in a single sample of spot urine.

Objective: To rapidly determine the relationship between tumor markers and adrenaline in the patient’s urine at the moment a hypertensive crisis occurs.

METHYLMALONIC ACID (MMA), Serum

Description: This is the blood level of a very specific acid that begins to accumulate in cells when the body is deficient in vitamin B12.

Purpose: To provide the earliest and most definitive diagnosis of "hidden B12 deficiency," a condition that begins at the cellular level despite appearing normal in standard blood tests.

Genetic, Prenatal, and Oncology Testing

MATERNAL CONTAMINATION

Description: This test determines whether the mother’s genetic cells have mixed with the fetal samples obtained through amniocentesis (fluid sampling) during pregnancy.

Objective: To confirm that genetic tests for Down syndrome and other conditions performed before birth are 100% specific to the fetus and to prevent misdiagnosis.

Myelodysplastic Syndrome (MDS) Deletion and Duplication Analysis

Description: In MDS, a condition in which the bone marrow is unable to produce healthy blood, this is a molecular screening for specific losses (deletions) or gains (duplications) in DNA.

Purpose: To predict the direction of treatment by mapping the genetic profile of the disease.

MONOSOMY / TRISOMY 8

Description: This is a cytogenetic analysis to determine the presence of a deficiency (monosomy) or an extra copy (trisomy) of chromosome 8 in the human genome.

Objective: To determine the patient’s clinical risk group (aggressiveness) in blood cancers such as acute leukemia and myelodysplastic syndrome (MDS).

MPL Mutation Analysis

Description: Detection of acquired mutations in the MPL gene that trigger excessive production of blood platelets (thrombocytes) in the bone marrow.

Purpose: To establish a definitive genetic diagnosis of essential thrombocythemia and primary myelofibrosis (bone marrow fibrosis).

Multiple Myeloma (MM) Panel

Description: This comprehensive panel simultaneously screens for all critical genetic and chromosomal abnormalities specific to multiple myeloma, a plasma cell cancer of the bone marrow.

Objective: To confirm the type of cancer, assess the aggressiveness of the disease, and develop the most appropriate personalized treatment plan (chemotherapy) for the patient.

MYELODYSPLASTIC SYNDROME (MDS) PANEL

Description: This process involves the simultaneous mapping of the numerous different genetic mutations observed in MDS, a condition that causes bone marrow failure in older adults.

Purpose: This test is requested to predict the rate at which the disease will progress to Acute Myeloid Leukemia (AML) and to determine whether the patient requires a bone marrow transplant.

Immunology, Autoimmunity, and Allergy Tests

Wide Panel of Myositis (Anti-Synthetase) Antibodies

Description: A comprehensive analysis of autoantibodies that cause the immune system to go out of control and attack the patient’s own skeletal muscle cells (and lung tissue).

Purpose: This test is used for the definitive diagnosis of rare rheumatic diseases, such as polymyositis, dermatomyositis, and anti-synthetase syndrome, which are characterized by muscle wasting.

Molecular Allergy Test

Description: This involves screening for IgE antibodies developed against hundreds of different allergens—such as food, pollen, house dust mites, or bee venom—at the molecular level using "chips (nanotechnology)" from a single blood sample.

Objective: Unlike traditional skin tests, the goal is to clearly distinguish between cross-reactions and to plan the most appropriate personalized vaccine (immunotherapy) treatment.

BANANA (Banana f92) CLIA

Description: This is a chemiluminescence immunoassay (CLIA) for the detection of IgE-class allergy antibodies produced by the immune system in response to proteins found in bananas.

Objective: To identify food allergies and assess the risk of the dangerous "Latex-Fruit Syndrome" (latex cross-allergy), which is commonly observed in individuals with banana allergies.

Microbiology and PCR Tests

SEARCH FOR MUSHROOMS, NAIL

Description: This procedure involves scraping keratin tissue from a problematic nail with abnormal shape or color, applying special solutions to the sample, and examining it directly under a microscope for fungal hyphae (threads).

Purpose: To quickly determine whether nail damage is caused by a fungal infection (onychomycosis) and to initiate medication treatment.

Mycobacterium Culture

Description: This involves the cultivation of slow-growing bacteria that cause tuberculosis (TB) by monitoring them for weeks in specialized tubes or culture media in a laboratory setting.

Purpose: To confirm a tuberculosis diagnosis with 100% accuracy and to determine which tuberculosis medications the cultured bacteria are resistant to (antibiogram).

Mycobacterium tuberculosis DNA PCR

Description: This is a molecular screening test that detects DNA sequences in sputum or other bodily fluids within seconds, regardless of whether the tuberculosis bacteria are alive or not.

Objective: Rather than waiting weeks for culture results, the goal is to diagnose tuberculosis—a potentially fatal disease—within hours.

Mycoplasma Pneumonia IgM and IgG

Description: This test detects acute (IgM) and persistent (IgG) antibodies in the blood against "Mycoplasma," an atypical bacterium commonly transmitted in schools and crowded environments.

Purpose: To identify the underlying cause of "atypical pneumonia" (pneumonia) characterized by a persistent, dry cough and fever lasting for weeks.

Toxicology and Trace Elements

MANGANESE Serum

Description: This refers to the blood level of manganese, a heavy metal that is essential for human health but can be neurotoxic (nerve-damaging) at high doses.

Objective: To monitor occupational exposure among workers in the mining and resources (industrial) sectors and to investigate the causes of Parkinson’s-like hand tremors.

MOLYBDENUM Serum

Description: This test measures the concentration of molybdenum—a trace element essential for the proper functioning of key metabolic enzymes in the body—in the blood.

Purpose: To determine whether there are any deficiencies in intensive care patients receiving intravenous (IV) nutrition and to screen for poisoning due to environmental exposure.



This content was prepared by Egemed Hospitals.

Published: April 9, 2026 - 10:05 PM • Last Updated: April 9, 2026